9 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
to which new drugs will be covered. Some third-party payors may require pre-approval of coverage for new or innovative devices or therapies before
10-Q
2023 Q1
SLRN
Acelyrin Inc
15 Jun 23
Quarterly report
4:19pm
in determining the extent to which new drugs will be covered. Some third-party payors may require pre-approval of coverage for new or innovative
424B4
djhi70wdzpt1khg
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
6470t
1 May 23
IPO registration (amended)
6:10am
S-1
8bmq5kkw
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next